Hence, IDH-mutated NSCLC can be clearly distinguished from IDH wildtype cases by MALDI-MSI, as detected intensities of oncometabolite 2HG were found to be 45 times higher than the average level in tumor regions. The gene discussed is IDH1; the disease is non-small cell lung carcinoma.